The PRAME-AS knockout cells showed a decrease in migration, proliferation, stemness, and viability. by Zahra Hosseininia (22265113)

Claudin V is decreased following infection with Mtb. by Amanda S. Latham (12093638)

“…Representative images of the frontal cortex (A–D), cerebral nuclei (F–I), brain stem (K–N), thalamus (P–S), and hippocampus (U–X) 15 days post-infection are shown. …”

NSC population and proliferation decrease drastically during the second postnatal week of DG development. by Cristina Medina-Menéndez (21800157)

Mean sediment transport (g m^-2 day^-1) by season (Spring, Summer, Winter). by Andrew Kulmatiski (833256)

Subjects:

Mean sediment transport (g m^-2 day^-1) by grazing condition (Grazed, Some Graze, and No Graze). by Andrew Kulmatiski (833256)

Subjects:

Average days (mean) to heal a wound in 2022 and 2023. by Heba Tallah Mohammed (2822432)

Association between the mean of the daily mean temperatures for the previous 7 days and AAD onset by subset analysis. by Ayami Ishikawa (19838027)

Subjects:

Cronbach’s alpha and means the stigma of Suicide Scale Short Form (SOSS-SF). by Orrin D. Ware (14829115)

Subjects:

Astrocytes increase contact with vessels and expression of AQP4 following Mtb infection, which is decreased in cytosis⁺ animals. by Amanda S. Latham (12093638)

“…Representative images of the frontal cortex (A–D), cerebral nuclei (G–J), brain stem (M–P), thalamus (S–V), and hippocampus (Y–BB) 15 days post-infection are shown. …”

Antibody and antigen responses to Lufotrelvir vs placebo day 1–90. by Elizabeth S. Munroe (21568166)

Antibody and antigen responses to Ensovibep vs placebo day 1–90. by Elizabeth S. Munroe (21568166)

Longitudinal antibody and antigen responses to treatment vs placebo day 1–90 for nMAbs, among patients alive and with day 90 antibody and antigen measures (Sensitivity Analysis). by Elizabeth S. Munroe (21568166)

Mean daily sediment transport (g m^-2 day^-1) under different vegetation types and soil cover in southeastern Utah, USA, 2004 to 2018. by Andrew Kulmatiski (833256)

Subjects:

Longitudinal antibody and antigen responses to treatment vs placebo day 1–90 for neutralizing monoclonal antibodies, among patients alive and with day 90 antibody and antigen measu... by Elizabeth S. Munroe (21568166)

Mean cocaine consumed (mg/kg) over 10 days. by Christopher Rowan (21499924)

Larger example of stimuli with cue relevant for Task 3. by Marcel F. Hinss (14675457)

Antibody and antigen responses to nMAb vs placebo day 1–90 for Sotrovimab. by Elizabeth S. Munroe (21568166)

Antibody and antigen responses to nMAb vs placebo day 1–90 for Bamlanivimab. by Elizabeth S. Munroe (21568166)

Antibody and antigen responses to nMAb vs placebo day 1–90 for Amubarvimab/ Romlusevimab. by Elizabeth S. Munroe (21568166)

Antibody and antigen responses to nMAb vs placebo day 1–90 for Tixagevimab/ Cilgavimab. by Elizabeth S. Munroe (21568166)